Indra Dias
Papers
1
Total Citations
12
H-Index
1
About
Dr. Indra Dias is a pioneering clinician-scientist whose research lies at the intersection of radiation oncology and ophthalmology, with a primary focus on neovascular age-related macular degeneration (nAMD). Her most significant contribution is leading the landmark STAR trial—a pivotal, randomised, double-masked, sham-controlled device study evaluating stereotactic radiotherapy for nAMD. This work, published in 2024, demonstrated that ionising radiation can mitigate key pathogenic processes underlying nAMD, offering a potential non-invasive alternative or adjunct to the standard anti-VEGF injections. With 12 citations in its first year, the STAR trial has already reshaped discussions around treatment paradigms for a leading cause of blindness. Dr. Dias’s research addresses the critical unmet need for reducing treatment burden in nAMD patients, who typically require frequent intravitreal injections. Her work is notable for its rigorous trial design and translational impact, bridging radiation biology and retinal disease. By exploring how targeted radiation can complement or replace biologic therapies, Dr. Dias is advancing a new frontier in ophthalmology, positioning herself as a key voice in the quest for durable, less invasive treatments for age-related vision loss.
Research Focus
Key Achievements
Top Papers
- 1